Will GSK recover reputation through its ambitious products?
GSK, which has been frozen in performance, a company specializing in vaccines, has taken the first step for its revival.
The company recorded low performance in its ambitious products, such as the pneumococcus vaccine ‘Synflorix,’ and the cervical cancer vaccine ‘Cervarix,’ through competing aga...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
